CD16- natural killer cells: Enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection

Blood

Volumn 115, Issue 22, 2010, Pages 4439-4446

  Reeves, R Keith ^a   Gillis, Jacqueline ^a   Wong, Fay E ^a   Yu, Yi ^a   Connole, Michelle ^a   Johnson, R Paul ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; CELL MARKER; CHEMOKINE RECEPTOR CCR7; CYTOKINE; GRANZYME B; L SELECTIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; PERFORIN; FC RECEPTOR; GRANZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BLOOD; CELL FUNCTION; CELL HETEROGENEITY; CELL MIGRATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOLYSIS; DOWN REGULATION; LYMPH NODE; LYMPHOID TISSUE; MUCOSA CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; UPREGULATION; VIRUS INFECTION; ANIMAL; BIOSYNTHESIS; CLASSIFICATION; CYTOTOXICITY; DEGRANULATION; FEMALE; IMMUNOLOGY; MACACA; MALE; METABOLISM; MUCOSA; PATHOLOGY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME;

ANIMALS; ANTIGENS, CD56; CELL DEGRANULATION; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GRANZYMES; KILLER CELLS, NATURAL; LYMPHOID TISSUE; MACACA MULATTA; MALE; MUCOUS MEMBRANE; PERFORIN; RECEPTORS, IGG; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME;

EID: 77953935526     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-01-265595     Document Type: Article

References (50)

1. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol. 2003;3(10):781-790.
2. Biassoni R. Human natural killer receptors, coreceptors, and their ligands. Curr Protoc Immunol. 2009;Chapter 14:Unit 14.10.
3. Bryceson YT, Long EO. Line of attack: NK cell specificity and integration of signals. Curr Opin Immunol. 2008;20(3):344-352.
4. Cooper MA, Fehniger TA, Fuchs A, Colonna M, Caligiuri MA. NK cell and DC interactions. Trends Immunol. 2004;25(1):47-52.
5. Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature. 2009; 457(7229):557-561.
6. Ibegbu C, Brodie-Hill A, Kourtis AP, et al. Use of human CD3 monoclonal antibody for accurate CD4+ and CD8+ lymphocyte determinations in macaques: phenotypic characterization of the CD3- CD8+ cell subset. J Med Primatol. 2001;30(6):291-298. (Pubitemid 34163101)
7. Carver FM, Thomas JM. Natural killer cells in rhesus monkeys: properties of effector cells which lyse Raji targets. Cell Immunol. 1988;117(1):56-69.
8. Carter DL, Shieh TM, Blosser RL, et al. CD56 identifies monocytes and not natural killer cells in rhesus macaques. Cytometry. 1999;37(1):41-50.
9. Wei Q, Stallworth JW, Vance PJ, Hoxie JA, Fultz PN. Simian immunodeficiency virus (SIV)/immunoglobulin G immune complexes in SIV-infected macaques block detection of C16 but not cytolytic activity of natural killer cell. Clin Vaccine Immunol. 2006;13(7):768-778.
10. Webster RL, Johnson RP. Delineation of multiple subpopulations of natural killer cells in rhesus macaques. Immunology. 2005;115:206-214. (Pubitemid 40733406)
11. Pereira LE, Johnson RP, Ansari AA. Sooty mangabeys and rhesus macaques exhibit significant divergent natural killer cell responses during both acute and chronic phases of SIV infection. Cell Immunol. 2008;254(1):10-19.
12. bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood. 2003;101(8):3052-3057.
13. Campbell JJ, Qin S, Unutmaz D, et al. Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol. 2001;166(11):6477-6482. (Pubitemid 32467184)
14. Ferlazzo G, Thomas D, Lin SL, et al. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol. 2004;172(3):1455-1462. (Pubitemid 38116788)
15. + immune precursors reside in human adult intestine and differentiate into natural killer cells. Gastroenterology. 2007;133(2):559-573.
16. Wira CR, Fahey JV, Sentman CL, Pioli PA, Shen L. Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev. 2005;206:306-335. (Pubitemid 41105178)
17. Lanier LL. Evolutionary struggles between NK cells and viruses. Nat Rev Immunol. 2008;8(4):259-268.
18. Gazit R, Gruda R, Elboim M, et al. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol. 2006;7(5):517-523.
19. Bonaparte MI, Barker E. Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules. Blood. 2004;104(7):2087-2094. (Pubitemid 39297862)
20. Fogli M, Mavilio D, Brunetta E, et al. Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals. PLoS Pathog (doi: 10.1371/journal.ppat. 1000101). 2008;4(7):e1000101.
21. Ward J, Bonaparte M, Sacks J, et al. HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts. Blood. 2007;110(4):1207-1214.
22. Chung AW, Rollman E, Center RJ, Kent SJ, Stratov I. Rapid degranulation of NK cells following activation by HIV-specific antibodies. J Immunol. 2009;182(2):1202-1210.
23. Fehniger TA, Herbein G, Yu H, et al. Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection. J Immunol. 1998;161(11):6433-6438. (Pubitemid 28536022)
24. O'Connor GM, HolmesA,Mulcahy F, Gardiner CM. Natural killer cells from long-term non-progressor HIV patients are characterized by altered phenotype and function. Clin Immunol. 2007;124(3):277-283.
25. Alter G, Teigen N, Davis BT, et al. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood. 2005;106(10):3366-3369.
26. Martin MP, Gao X, Lee JH, et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet. 2002;31(4):429-434.
27. Martin MP, Qi Y, Gao X, et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet. 2007;39(6):733-740.
28. Giavedoni LD, Velasquillo MC, Parodi LM, Hubbard GB, Hodara VL. Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus. J Virol. 2000;74(4):1648-1657.
29. Shieh TM, Carter DL, Blosser RL, Mankowski JL, Zink MC, Clements JE. Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus. J Neurovirol. 2001;7(1):11-24.
30. Bostik P, Kobkitjaroen J, Tang W, et al. Decreased NK cell frequency and function is associated with increased risk of KIR3DL allele polymorphism in simian immunodeficiency virus-infected rhesus macaques with high viral loads. J Immunol. 2009;182(6):3638-3649.
31. Choi EI, Reimann KA, Letvin NL. In vivo natural killer cell depletion during primary simian immunodeficiency virus infection in rhesus monkeys. J Virol. 2008;82(13):6758-6761.
32. Abdel-Motal UM, Gillis J, Manson K, et al. Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques. Virology. 2005;333(2):226-238.
33. Macchia I, Gauduin MC, Kaur A, Johnson RP. Expression of CD8alpha identifies a distinct subset of effector memory CD4+ T lymphocytes. Immunology. 2006;119(2):232-242.
34. Reeves RK, Gillis J, Wong FE, Johnson RP. Vaccination with SIVdeltanef activates CD4+ T cells in the absence of CD4+ T cell loss. J Med Primatol. 2009;38(suppl 1):18-16.
35. Cline AN, Bess JW, PiatakMJr, Lifson JD. Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS. J Med Primatol. 2005;34(5-6):303-312.
36. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol. 2001;22(11):633-640.
37. Brown KN, Trichel A, Barratt-Boyes SM. Parallel loss of myeloid and plasmacytoid dendritic cells from blood and lymphoid tissue in simian AIDS. J Immunol. 2007;178(11):6958-6967.
38. Choi EI, Wang R, Peterson L, Letvin NL, Reimann KA. Use of an anti-CD16 antibody for in vivo depletion of natural killer cells in rhesus macaques. Immunology. 2008;124(2):215-222.
39. Alter G, Teigen N, Ahern R, et al. Evolution of innate and adaptive effector cell functions during acute HIV-1 infection. J Infect Dis. 2007;195(10):1452-1460.
40. Beider K, Nagler A, Wald O, et al. Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice. Blood. 2003;102(6):1951-1958.
41. Grégoire C, Cognet C, Chasson L, et al. Intrasplenic trafficking of natural killer cells is redirected by chemokines upon inflammation. Eur J Immunol. 2008;38(8):2076-2084.
42. Ottaviani C, Nasorri F, Bedini C, de Pita O, Girolomoni G, Cavani A. CD56brightCD16-NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur J Immunol. 2006;36(1):118-128.
43. Nagler A, Lanier LL, Cwirla S, Phillips JH. Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol. 1989;143(10):3183-3191.
44. LaBonte ML, McKay PF, Letvin NL. Evidence of NK cell dysfunction in SIV-infected rhesus monkeys: impairment of cytokine secretion and NKG2C/C2 expression. Eur J Immunol. 2006;36(9):2424-2433.
45. Mavilio D, Benjamin J, Daucher M, et al. Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc Natl Acad Sci U SA. 2003;100(25):15011- 15016.
46. Giuliani M, Giron-Michel J, Negrini S, et al. Generation of a novel regulatory NK cell subset from peripheral blood CD34+ progenitors promoted by membrane-bound IL-15. PLoS ONE (doi:10.1371/journal.pone.000224). 2008;3(5):e2241.
47. Frey M, Packianathan NB, Fehniger TA, et al. Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets. J Immunol. 1998;161(1):400-408.
48. Mailliard RB, Alber SM, Shen H, et al. IL-18-induced CD83+CCR7+ NK helper cells. J Exp Med. 2005;202(7):941-953.
49. Boisvert J, Kunkel EJ, Campbell JJ, Keeffe EB, Butcher EC, Greenberg HB. Liver-infiltrating lymphocytes in end-stage hepatitis C virus: subsets, activation status, and chemokine receptor phenotypes. J Hepatol. 2003;38(1):67-75.
50. Alter G, Martin MP, Teigen N, et al. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med. 2007;204(12):3027-3036.